Cymbalta gains indication for chronic musculoskeletal pain - ONA

Links shared publicly online about this topic.

  • 749
    total visits

Cymbalta gains indication for chronic musculoskeletal pain - ONA

oncologynurseadvisor.com

Lilly announced that Cymbalta (duloxetine HCl) has gained an indication for the management of chronic musculoskeletal pain, including chronic osteoarthritis pain and chronic low back pain.

View full resource at oncologynurseadvisor.com

Tags: Pain, Anxiety Medication, Antidepressant, Musculoskeletal, Fibromyalgia Medication, Neuropathic Pain Medication, Cymbalta

  • Share

Most Recently Shared on November 5, 2010 at 1:43 pm By:

ONAcom OncologyNurseAdvisor

Cymbalta gains indication for chronic musculoskeletal pain http://goo.gl/fb/RM0Ib

1 year ago...

Advertisement